Immune-related adverse events predict responses to PD-1 blockade immunotherapy in hepatocellular carcinoma. Lu L, Xing K, Wei W, Ling Y, et al. Int J Cancer 2021 Apr 22. doi: 10.1002/ijc.33609.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lu L, Xing K, Wei W, Ling Y, et al. Immune-related adverse events predict responses to PD-1 blockade immunotherapy in hepatocellular carcinoma. Int J Cancer 2021 Apr 22. doi: 10.1002/ijc.33609.
PMID: 33890283